All News

Alzheimer’s and other neurodegenerative diseases are Europe’s latest big health issue, new MEP Antonio Fernando Correia de Campos tells Science|Business.

Cost conundrum: the investment in clinical trials remains the same but approved drugs will have a smaller market. So how is Personalised Medicine to be financed?

With 20 years of experience behind him, ACES winner Nigel Brown believes companies today spend too much money – and energy – on water purification.